Yunkang Group (HKSE:02325) Cash-to-Debt : 1.35 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Yunkang Group's cash to debt ratio for the quarter that ended in Dec. 2023 was 1.35.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Yunkang Group could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Yunkang Group's Cash-to-Debt or its related term are showing as below:

HKSE:02325' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.31 Med: 1.58 Max: 2.21
Current: 1.35

During the past 6 years, Yunkang Group's highest Cash to Debt Ratio was 2.21. The lowest was 0.31. And the median was 1.58.

HKSE:02325's Cash-to-Debt is ranked better than
51.1% of 227 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.3 vs HKSE:02325: 1.35

Yunkang Group Cash-to-Debt Historical Data

The historical data trend for Yunkang Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Yunkang Group Cash-to-Debt Chart

Yunkang Group Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.31

0.98

2.21

1.82

1.35

Yunkang Group Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial				2.21	2.35	1.82	1.68	1.35

Competitive Comparison of Yunkang Group's Cash-to-Debt

For the Diagnostics & Research subindustry, Yunkang Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yunkang Group's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Yunkang Group's Cash-to-Debt falls into.

Yunkang Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Yunkang Group's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2046.163	/	(1280.118	+	240.058)
	=	1.35

Yunkang Group's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2046.163	/	(1280.118	+	240.058)
	=	1.35

Yunkang Group (HKSE:02325) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Yunkang Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Yunkang Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Yunkang Group (HKSE:02325) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6 Lizhishan Road, Science City, Huangpu District, Guangzhou, CHN

Website

http://www.yunkanghealth.com

Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.

Executives

Huizekx Limited	2201 Interest of corporation controlled by you
Yk Development Limited	2101 Beneficial owner
Zhang Yong	2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd	2201 Interest of corporation controlled by you
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si	2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si	2201 Interest of corporation controlled by you
Jin Jun Ying Limited	2201 Interest of corporation controlled by you
Mouduans Limited	2201 Interest of corporation controlled by you
Source Capital Rw Limited	2201 Interest of corporation controlled by you
Tongfuzc Limited	2201 Interest of corporation controlled by you
Wjjr Investment Limited	2201 Interest of corporation controlled by you

Yunkang Group (HKSE:02325) Headlines

No Headlines